-
Start Preamble
SUMMARY:
In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the National Heart, Lung, and Blood Institute (NHLBI), the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) The accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Ways to enhance the quality, utility, and clarity of the information to be collected; and (4) Ways to minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology.
To Submit Comments and for Further Information: To request more information on the proposed project or to obtain a copy of data collection plans and instruments, contact Dr. Gina Wei, Division of Cardiovascular Sciences, NHLBI, NIH, Two Rockledge Center, 6701 Rockledge Drive, MSC 7936, Bethesda, MD 20892-7936, or call non-toll-free number (301) 435-0456, or email your request, including your address to: weig@nhlbi.nih.gov. Formal requests for additional plans and instruments must be requested in writing.Start Printed Page 26640
Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication.
Proposed Collection: The Framingham Heart Study, 0925-0216, Extension, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH).
Need and Use of Information Collection: The Framingham Heart Study will continue to conduct morbidity and mortality follow-up, as well as examinations, for the purpose of studying the determinants of cardiovascular disease. Morbidity and mortality follow-up will continue to occur in all of the cohorts (Original, Offspring, Third Generation, Omni Group 1, and Omni Group 2). Examinations will continue to be conducted on the Original, Offspring, and Omni Group 1 Cohorts.
OMB approval is requested for 3 years. There is no cost to the respondents other than their time. The total estimated annualized burden hours are 4264.
Estimated Annualized Burden Hours, Original Cohort
Type of respondent Number of respondents Number of responses per respondent Average time per response (in hours) Total annual burden hour I. Participant Components a. Telephone contact to set up appointment 60 1 10/60 10 b. Exam Appointment, Scheduling, Reminder, and Instructions 55 1 35/60 32 B. Exam—Cycle 32: a. Clinic exam 25 1 45/60 19 b. Home or nursing home visit 25 1 65/60 27 C. Annual Follow-up: a. Records Request 60 1 15/60 15 b. Health Status Update 45 1 15/60 11 Sub-Total: Participant Components * 60 114 II. Non-Participant Components A. Informant Contact (Pre-exam and Annual Follow-up) 25 1 10/60 4 B. Records Request (Annual follow-up) 50 1 15/60 13 Sub-Total: Non-Participant Components 75 17 * Number of participants as reflected in Rows I.A.a and I.C.a. above. Estimated Annualized Burden Hours, Offspring Cohort and Omni Group 1 Cohort
Type of respondent Number of respondents Number of responses per respondent Average time per response (in hours) Total annual burden hour I. Participant Components: A. Pre-Exam: a. Telephone contact to set up apt or Health status update 300 1 10/60 50 b. Appt. or update Confirmation 250 1 10/60 42 c. Food Frequency Form 250 1 10/60 42 B. Exam: a. Clinic Exam 100 1 175/60 292 b. Home or nursing home visit 100 1 60/60 100 c. Consent Forms 200 1 20/60 67 C. Annual Follow-Up: a. Records Request 2292 1 15/60 573 b. Health Status Update 1833 1 15/60 458 Sub-Total: Participant Components * 2292 1624 II. Non-Participant Components: A. Informant contact (Pre-exam and Annual Follow-up) 229 1 10/60 38 B. Records Request (Annual follow-up) 2292 1 15/60 573 Sub-Total: Non-Participant Components: 2521 611 * Number of participants as reflected in Rows I.C.a. above. Estimated Annualized Burden Hours, Generation 3 Cohort and Omni Group 2 Cohort
Type of respondent Number of respondents Number of responses per respondent Average time per response (in hours) Total annual burden hour I. Participant Components Annual Follow-up: 1 A. Records Request 3212 1 15/60 803 Start Printed Page 26641 B. Health Status Update 3212 1 15/60 803 Sub-Total: Participant Components * 3212 1606 II. Non-Participant Components Annual Follow-up: A. Informant contacts 160 1 10/60 27 B. Records Request 1060 1 15/60 265 Sub-Total: Non-Participant Components 1220 292 * Number of participants as reflected in Rows I.A. and I.B. above. Start SignatureSummary of 3 Tables Combined—Total Estimated Annualized Burden Hours
Type of respondent Number of respondents Number of responses per respondent Average time per response (in hours) Total annual burden hour Participants 5564 1 36/60 3344 Non-Participants 3816 1 14.5/60 920 Totals 9380 4264 (Note: reported and calculated numbers differ slightly due to rounding.) Dated: April 25, 2013.
Lynn Susulske,
NHLBI Project Clearance Liaison, National Institutes of Health.
Michael Lauer,
Director, DCVS, National Institutes of Health.
[FR Doc. 2013-10771 Filed 5-6-13; 8:45 am]
BILLING CODE 4140-01-P
Document Information
- Comments Received:
- 0 Comments
- Published:
- 05/07/2013
- Department:
- National Institutes of Health
- Entry Type:
- Notice
- Document Number:
- 2013-10771
- Dates:
- Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication.
- Pages:
- 26639-26641 (3 pages)
- PDF File:
- 2013-10771.pdf
- Supporting Documents:
- » License Agreements; Start-Up Exclusive Evaluation Option: Activators of Human Pyruvate Kinase to Treat Cancer
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: National Institute of Nursing Research
- » Meetings: National Institute of Allergy and Infectious Diseases
- » Meetings: National Eye Institute
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: Center for Scientific Review
- » Meetings: Center for Scientific Review
- » Meetings: National Institute of Environmental Health Sciences
- » Meetings: National Human Genome Research Institute